MBX Biosciences Company
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Headquarters:
Carmel, Indiana, United States
Total Funding:
$59.9M
Founded Date:
2019
Employee Number:
1-10
Last Funding Type:
Series A
Investor Type:
For Profit
Investors Number:
6
Technology:
Others
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
PharmTech